• Home
  • Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.

Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.

Author List
Miller PD, Pannacciulli N, Wagman RB, Cummings SR
Publication
The Journal of clinical endocrinology and metabolism
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1204975
Publication Year
2016
PubMed ID
27600206
Publication Title
Miller PD, Pannacciulli N, Wagman RB, Cummings SR. Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. J Clin Endocrinol Metab. 2016 09; 101(9):L91-2.